Operating room equipment market size is expected to reach USD 48.50 billion by 2025

The global operating room equipment market size was valued at USD 26.24 billion in 2016 and is expected to reach USD 48.50 billion by 2025, at CAGR of 7.2%. Growing demand for improved medical facilities coupled with transition from conventional to state-of-the-art operation theaters is anticipated to escalate the operating room equipment market over the forecast period. Technological transformations, infrastructural development and high investments in the medical devices by hospital and healthcare centers are expected to spur the medical equipment demand over the forecast period. Development of hybrid operating rooms has prompted the installation of multi-purpose equipment, enabling automated results coupled with high operational efficiency, providing ample space for the introduction of high end equipment.

High occurrence of medical disorders among geriatric population along with the prevalence life threatening diseases is anticipated to fuel advanced operating equipment demand. Availability of advanced surgical tools and high prevalence of chronic disorders or diseases is also anticipated to escalate product demand over the forecast period. Key challenge faced by the industry includes the high cost associated, which is expected to hamper introduction of these devices in hospitals. Lack of knowledge and skilled manpower required to handle complex devices is also expected to hinder market growth over the forecast period.  Rise in number of high-end operating rooms accompanying advanced equipment along with increasing number of ASC (Ambulatory Surgical Center) is anticipated to substantially drive the level of innovation among manufacturers instigating them to provide latest technologies.

Browse full research report:

https://www.millioninsights.com/industry-reports/operating-room-equipment-market

Advanced and efficient operating tables, surgical booms, operating room integration systems, operating room lights, surgical headlights, surgical light sources and surgical imaging display forms an integral part of the new age hybrid theaters. Further, anesthesia equipment, electrosurgical generators, defibrillators, respiratory ventilators, endoscopy equipment, vital sign monitors, pneumatic tourniquet, infusion pumps, surgery microscopes, medical stainless steel, patient warmers, suction pumps, hospital stretchers, medical warmers, hospital stretchers, autoclaves & sterilizers, sequential compression devices and vaporizers & accessories contributes essential functionalities to an operating theater.

Integration of non-surgical and surgical equipment in the hybrid operating rooms including patient monitoring, diagnostics and radiology among others coupled with imaging techniques such as MRI scanners, CT scanners and C- arm provides better ease and flexibility to the specialist to perform the task. Installation of hybrid operation rooms largely reduces the hustle of transferring a patient from the operation theater to the scanning center. This greatly automates the work efficiencies and results in better patient care, thereby adding to the business value.

Operating rooms presently require high-definition fixed imaging and video equipment, enabling information from all over the hospital at the surgeon’s fingertip, and are expected to drive the industry demand over the forecast period. The industry is witnessing a growing trend towards installation of larger imaging systems. Operating rooms today are an economic engine for any medical facility, and accounts for more than 60% of the revenue. Further, hospitals often face an increasing drive for patient oriented effectiveness. Hospitals need to focus on creating value for the patient with the installation of state-of-the-art equipment with a combination of optimally trained medical expert. In addition, optimizing the operation environment helps enhance surgeon performance, and is thereby expected to drive the operating equipment market over the forecast period.

Europe and North America are expected to emerge as the largest markets due to existence of well-established medical sector with the presence of technologically advanced medical systems. The regions are expected to witness significant growth due to the upgradation of technology with advanced automated systems and rise in number of hospitals. Evolving medical industry in the Asia Pacific region including India, Thailand, Malaysia and South Korea due to rise in population encourages the medical sector to install high-end medical facilities and technologies at low costs.

Major players in the market include Steris Corporation, Hill-Rom Holding Inc., GE Healthcare, Phillips Healthcare, Stryker Corporation, Mizuho OSI, Getinge Group, Dragerwerk, Medtronic Inc, Eschmann Equipment, Karl Storz GmBH & Co. KG, Skytron, NDS Surgical Imaging, Berchtold Corporation, Trumpf GmBH + Co. KG, Creative Heath Tech Pvt. Ltd., Siemens Healthcare.

To get free request sample:

https://www.millioninsights.com/industry-reports/operating-room-equipment-market/request-sample

The healthcare market is majorly driven by the cheap availability of highly efficient systems and tags

Industry Insights

Global RFID in healthcare market was valued at USD 646.7 million in 2014 and is expected to reach over USD 3.89 billion over the next seven years. Key influences attributing to this rapid growth include growing occurrences of theft and loss of different medical devices which result in high losses to the pharmacies and hospitals. Healthcare services use radio frequency identification (RFID) and real-time location systems (RTLS) to track, identify, monitor patients, locate, visitors, assets, equipment and staff. Know that, how of these technologies aid in improving safety, enhancing the quality of care, reducing financial waste, and fostering patient satisfaction.

The healthcare market is majorly driven by the cheap availability of highly efficient systems and tags. Improper storage systems and careless handling in pharmaceutical stores have led to rising number of stock outs and expiration of medicines. This, in turn, may impact in loss of revenue and reputation which is anticipated to encourage better usage in the foreseeable future.

Furthermore, one of the high impact rendering drivers for the growth of this market is the development and rising usage of Kanban systems in order to achieve lean inventory. RFID Kanban systems allow organizations to lessen their inventory value by 15-35% according to a study shown by Stanley Healthcare. In addition, with inventory reduction by 50%, the inventory replenishment expenses can be condensed down to a total expenditure of just 5% of overall. Furthermore, these changes are anticipated to cut down on the storage space by 22%. As a result, storage costs are reduced substantially subsequently decreasing energy costs as well.

Browse full research report:

https://www.millioninsights.com/industry-reports/rfid-in-healthcare-market

Implementation of advanced Kanban systems in existing hospital inventory management and timely placement of orders to the supplier directly for requisite medical devices and medication is expected to encourage hospitals and pharmacies to incorporate these systems. RFID systems find widespread applications in the healthcare sector and have an increasing penetration in areas including infection control, injection safety, tracking prescription drugs and radiology. These systems are anticipated to improve market capitalization in coming seven years. For instance, Sanraku Hospital collaborated with BayNexusin an attempt to manage their medical equipment efficiently. Which also, to reduce time taken to inspect medical conditions, Wake Forest Baptist Medical Center integrated RFID tags on the closures of x-ray vests.

Product Insights

On the basis of product type, RFID systems and tags are segmented into two main products. In 2014, RFID systems contributed to over 55% of the overall market share. Key factors contributing to this large share includes high penetration of these devices in the market owing to better awareness levels regarding the advantages of RFID devices such as their ability to embed into existing hospital ERP software systems and reduction in overall operational costs. Systems are further categorized as pharmaceutical tracking, asset tracking, blood monitoring and patient tracking.

In 2014, the pharmaceutical segment constituted for the largest share and is projected to emerge as the dominant market leader in the next seven years. RFID tags cost approximately 4-6 cents which turn to be cost effective and may render as a high impact driver for market growth in the next seven years. Additionally, tags market is also sub divided on the basis of their end-use in varies departments including pharmaceutical tracking tags, asset tracking tags, blood monitoring tags and patient tracking tags.

Download free request sample:

https://www.millioninsights.com/industry-reports/rfid-in-healthcare-market/request-sample

Regional Insights

Asia-Pacific, North America, Latin America, MEA and Europe are key regional markets. In 2014, North America was the dominant market player which captured over 50% of the overall share. Key factors accrediting to its large share include the existence of developed healthcare infrastructure together with high awareness levels about the advantages of these systems.

Further, in November 2013, U.S. president entered into a contract with The Drug Quality and Security Act (DQSA) that outlines essential steps to form an interoperable and electronic system that could trace and ascertain prescription drugs while they are distributed in the United States. The usage of RFID tags and systems in the U.S. is expected to rise owing to the emergence of aforementioned steps over the forecast period.

However, Asia Pacific is projected to grow at a rapid over the forecast period. New multinational hospital chains, continuously improving healthcare infrastructure and favourable government initiatives in the region will considerably propel growth in Asia Pacific market.

Market Share Insights

Key performers functioning in the industry include Terson Solutions, Log Tag, Solstice Medical LLC, Mobile Aspects Inc, Logi Tag, Wave Mark, Hurst Green Plastics Ltd., Pepperl+Fuchs, Tagsys RFID Group, Metra Tec GmbH, Wurth Group, Bollhoff Group, Stanley Innerspace, Brooks Automation, Grifols and Datelka.

Teleradiology makes it easy to remit images as it is to remit emails that have attachment

The global Teleradiology Market size is expected to reach USD 8.2 billion by 2024, with a CAGR of over 19.1%. Teleradiology can be defined as the exercise of a radiologist which interprets (reading) medical descriptions about those who are not actually there in the place where the descriptions are generated. Portable imaging companies, hospitals, imperative care facilities and even few personal practices utilize teleradiology services. Teleradiology services can reduce the patient worries by making it achievable for radiologists to offer their services excepting the need to be in the same place. In past few years, teleradiology was barely use in emergency, owing to the internet; this exercise started spreading very fast. Teleradiology makes it easy to remit images as it is to remit emails that have attachment.

Computer programs are their which are devoted exclusively to the spread of radiological pictures. All these development end result in teleradiology service are turning into a noteworthy medical exercise and it carries on rising over the forecast period. Teleradiology services tend to link the breach between the unwarranted requirement and supply of diagnostic services and radiologists around the globe. Teleradiology services assist to transmit radiological images such as MRIs, CTS and MRI from one place to a different place for sharing the descriptive images among other physicians and radiologist. By utilizing technologies such as, Internet, cloud storage ,wide area network, local area network (LAN), telephone lines, as well as voice recognition, image compression, and, advanced graphics processing, teleradiology allows physicians to help their patients from a distant place, in addition ion to which making ‘second opinions ‘becomes much easier Electronic descriptive image transmission in the digital set-up is done with the intention to consult or diagnose, and the expansion and innovation in the area of digital imaging technology is expected to fuel the growth of the global teleradiology market over the forecast period.

In-Depth research report on Teleradiology Market:

https://www.millioninsights.com/industry-reports/teleradiology-market

Teleradiology generates the highest revenue and is the most mature segment of the industry in the telehealth technologies industry. Advancement in the field of digital technology has transformed the teleradiology services into an effectual means to transfer significant data about patients. Furthermore, technological advancement is expected to propel the growth of the global teleradiology market over the forecasted period. Increasing usage of cellular phones, personal digital assistants, patient monitoring systems and other wireless devices like mobile health services are expected to fuel the growth of the global teleradiology market over the forecasted period. Lack of security for imaging data coupled with the high cost of technology is likely to negatively shape the global teleradiology market over the forecast period. New developments in the field of global teleradiology such as radiology information systems (RIS)) and picture archiving and communication systems (PACS) is expected to open new opportunity for the market over the forecasted period.

Obligation to subordinate the healthcare expenditure has made the healthcare services provider to contract out the analysis of radiology images to budding and low-cost countries. The simplicity of entry for the new entrant in the teleradiology services has resulted in an advanced competition in the market, with a greater number of teleradiology service providers. Aforementioned factor is also expected to drive the growth telerdiology market over the forecast period. Increasing digitalization is also expected to help and improve the teleradiology market over the forecast period.

Browse reports of similar category available:

https://www.millioninsights.com/industry/healthcare

On The basis of various imaging modalities the global teleradiology market can be segregated into four major parts such as, magnetic resonance imaging (MRI), computed tomography (CT), nuclear imaging-ray and ultrasound. The X-ray section of global teleradiology market has dominated the larger part of teleradiology market in past few years. Moreover ultrasound imaging is expected to witness more preference over Xray and MRI over the forecasted period owing to fact as the patient is exposed to lesser amount of radiation. CT scan imaging technology is also increasing owing to fact as it allows more ability to detect abnormalities in the pancreas, liver and others. Increasing number of healthcare institution radiologic understanding of CT scans is also increasing. High costs attached and Shortage of technical skill to MRI and nuclear imaging are some of, the parts that will nurture slowly over the forecast period.

On the basis of region Global teleradiology market can be segregated into four parts that are .Asia Pacific, North America, Europe and others. In past few years North America has led the global teleradiology market. The foremost factors accountable for the enlargement of the teleradiology market in North America are rise in expenditure of healthcare companies, rapid innovation in medical approaches and well equipped hospitals. Asia Pacific is expected to see a faster growth rate over the forecast period owing to flourishing new companies in the Countries like India. Teleradiology services provider in India are capable of conquer the shortage of radiology services by providing imaging services to healthcare institution, when radiologists are not accessible in parts of North America such as US.

Time zone benefit is one more main thing that has been contributing the growth of teleradiology in India and is expected to drive the growth over the forecast period. The key vendors in Teleradiology market are Teleradiology Solutions, Sectra AB, Cybernet Systems Corporation, Virtual Radiologic, American Telecare Inc, and StatRad.

To get free request sample:

https://www.millioninsights.com/industry-reports/teleradiology-market/request-sample

Diabetes is a chronic disorder related with defects in the secretion of insulin from the hyperglycemia

The global Diabetic Retinopathy Market size is likely to reach USD 10.08 billion by 2025. Diabetes is a chronic disorder related with defects in the secretion of insulin from the hyperglycemia or pancreas associated to insulin resistance which eventually leads to long term multi-organ problems of kidneys, eye, blood vessels, nerves and heart.

Factors, such as increasing aged population, up-gradation of healthcare infrastructure, rising demand for initial detection systems, technological advancements, uncontrolled glucose levels and ignorance towards treatment, and increasing research activities towards developing advanced products are likely to drive the diabetic retinopathy industry in the forthcoming period.

On the other hand, lack of skilled professionals, presence of low-income groups, high cost associated with the treatment and poor availability to healthcare services are anticipated to hinder diabetic retinopathy market growth in future. However, prolonged undiagnosed diabetes is likely to create lucrative opportunities for the market. Diabetic retinopathy industry is anticipated to expand at a CAGR of 6.3% in the upcoming period as the scope, product types and its applications are increasing across the globe.

Browse full research report:

https://www.millioninsights.com/industry-reports/diabetic-retinopathy-market

Diabetic retinopathy market is segmented by type, treatment type, indications, end user and geography. The market is segmented by type as Proliferative Diabetic Retinopathy and Non-proliferative diabetic retinopathy. The “Non-proliferative diabetic retinopathy” segment accounted for a prominent share in the market. It is likely to witness substantial growth in the years to come. The key factors that could be attributed to the growth of market includes presence of huge number of patients (less than 10 years of diabetic history) and increased occurrence of diabetes.

Based on treatment type, the diabetic retinopathy industry is segmented by Vitrectomy, Steroid Implants, Anti VEGF Drug and Laser Surgeries. The “Anti VEGF Drug” segment accounted for a prominent share in the market. It is likely to witness a substantial growth in the years to come. The key factors that is could be attributed to the growth of market include mild to moderate cases of non-proliferative DR treatment, and better treatment and high applicability and faster recovery of these drugs in treatment of initial diagnosis.

The diabetic retinopathy market is segmented based on the end user as Ambulatory Surgical Centers, Hospitals and Ophthalmic Clinics. Based on indications, the market of diabetic retinopathy is segmented as Proliferative Diabetic Retinopathy (PDR) and Non-Proliferative Diabetic Retinopathy (NPDR) (Severe, Moderate and Mild).

North America is a leading region in the market. It is likely to maintain a dominance in the forecast period owing to factors, such as a large number of aged populations, increase in occurrence of diabetic retinopathy patients in the region, increasing healthcare infrastructure and rising health awareness among population. In addition, North America is followed by Asia-Pacific region owing to changing lifestyle of people in the region, surge in diabetic population, increase in funding and support provided by the government.

Key players operating in the diabetic retinopathy industry include Alimera Science, Abbott Laboratories, Allergan plc, Bayer AG, Ampio Pharmaceuticals., Novartis International AG, F. Hoffmann-La Roche, Pfizer, Valeant Pharmaceutical, Regeneron Pharmaceuticals Inc., KOWA Company, Ltd., Boehringer Ingelheim GmbH, ThromboGenics NV., and BCN Peptides S.A. The leading companies are involved in partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Download free request sample:

https://www.millioninsights.com/industry-reports/diabetic-retinopathy-market/request-sample

Rise in government initiatives to create awareness pertaining to contamination level in drugs & formulations coupled with R&D analysis

The global X-Ray photoelectron spectroscopy market is likely to cross USD 712.4 million owing to rise in demand for medical research, minimal medication error and technological progress. The market is driven by factors such as rise in government initiatives to create awareness pertaining to contamination level in drugs & formulations coupled with R&D analysis is expected propel the market growth. Rise in government regulations and certifications emphasizing drug safety for various raw materials and formulation are expected to contribute to the X-Ray photoelectron spectroscopy industry in the forthcoming period. However, significant costs of set up for new market entrants are likely to create hindrances in the market growth in the forecast period up to 2025.

Browse full research report:

https://www.millioninsights.com/industry-reports/x-ray-photoelectron-spectroscopy-xps-market

X-Ray photoelectron spectroscopy also termed as electron spectroscopy for chemical investigation is widely used to investigate chemical proportion of surfaces. The proliferated use of XPS in investigative laboratories across the globe acts as a problem solving capability of the technique. The capacity to discover the initial atomic layers to assign chemical states to the discovered atoms renders X-Ray photoelectron spectroscopy to be an optimal addition to any analytical theory.

X-Ray photoelectron spectroscopy market is segmented by use, application, and geography. Use segment dominates the market scenario owing to rise in diverse applicability such as element detection, density estimation, contamination detection and empirical formulation. Element detection accounts for significant market share during the forecast period owing to efficiency and accuracy offered. Contamination detection accounts for second position in the market share due to certain use of XPS for organic as well as inorganic contaminants. Rise in demand for systems & technologies to offer accurate results is additionally likely to contribute to the market growth in the forecast period.

Geographical segmentation for X-Ray photoelectron spectroscopy industry spans North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America X-Ray photoelectron spectroscopy market is expected to dominate the global market scenario owing to rise in application for XPS for medical research, existing technological evolution.

Favorable reimbursement is another factor adding to the X-Ray photoelectron spectroscopy market growth in the forecast period. Asia-Pacific’s X-Ray photoelectron spectroscopy industry is likely to contribute to the market growth due to wide presence of manufacturers and availability of favorable market conditions. The key players in the X-Ray photoelectron spectroscopy market include Thermo Fisher Scientific, Kratos Analytical, Evan Analytical Group (EAG), Intertek, V G Scienta, Yokogawa, Kett and Mitsubishi Electric.

Download free request sample:

https://www.millioninsights.com/industry-reports/x-ray-photoelectron-spectroscopy-xps-market/request-sample

Orthobiologics market provides a huge number of opportunities for growth to its shareholders

The global orthobiologics market size was valued at USD 5.0 Billion in 2015 and is anticipated to reach USD 10.2 billion by 2025, with a CAGR of 7.5%. Orthobiologics are elements which the orthopedic surgeons use to heal the wounds more quickly. They are utilized for the healing of injured muscles, ligaments, tendons, and broken bones. They are made up of substances found in the human body itself. These elements found popularity owing to factor such as faster healing, quick recovery, and a decrease in the number of hospital visits. The orthobiologics market provides a huge number of opportunities for growth to its shareholders.

The global orthobiologics market is poised for growth owing to the increased levels of geriatric population, technological advancements, changing lifestyles and problems related to the musculoskeletal system. The increasing trends of musculoskeletal procedures are seen to be the biggest driver for the market. Establishing strategic partnerships for the purpose of marketing is also expected to boost the demand for the global orthobiologics market. Several merchants are forming strategic partnerships to diversify their businesses, grow their overall market share and spread out their product offerings. These type of strategic alliances help the organizations to align their technologies with one another’s inventive medical device range.

A growth in the global orthobiologics market is projected on account of the requirement for safer, more effective and modern orthopedic biologic treatment. The rise in the number of obesity and arthritis cases also fuels the demand for orthobiologics treatment. The bone graft procedure accounted to be the largest segment in the global orthobiologics market.

Read full research report:

https://www.millioninsights.com/industry-reports/orthobiologics-market

The shifting preference to biological implants from mechanical implants is accelerating the growth of this market. Another important trend that is estimated to enhance the growth of the market over next eight years is the increase in funds to improve orthobiologics. Factors such as growing advances in technology, the prevalence of a huge number of chronic and unidentified diseases, initiatives by the government and rise in life expectation may favorably impact the market growth. Along with this, the rising incidences of injuries by sports & road accidents and growing awareness among athletes are also driving the demand for the market.

However, lack of clear reimbursement procedures and rigorous rules may create major hindrances for the orthobiologics demand in the market. The improvements in developing alternatives for pharmaceuticals, for making medical treatments more preventive than curative along with the country’s policy for decreasing the deficit in the budget is expected to negatively impact the global orthobiologics market. Furthermore, high costs for the procedure, lack of reliable clinical trial data and strict regulations for the approval of orthobiologics products may pose challenges to the market growth over the forecast period.

The global orthobiologics market has been segmented based on its applications and product types. On the basis of application, the market been classified into spinal surgery, joint replacement & reconstruction, and trauma surgery. On the basis of product types, the market has been segmented into bone graft substitutes, bone growth stimulators, and viscosupplements. The bone graft substitutes have further been segmented into demoralized bone matrix (DBM), bone morph genic proteins (BMP), bone allografts, and bone autographs. Additionally, viscosupplements has also been further segmented into single injection viscosupplements, 3-injection viscosupplements, and 5-injection viscosupplements.

Over the past few years, the viscosupplements segments held the largest market share for orthobiologics on account of huge demand for knee treatment procedures. It is a very effective pain killer. Viscosupplements are intra-articular injections made of hyaluronic acid which helps in the treatment of osteoarthritis.

Download free request sample:

https://www.millioninsights.com/industry-reports/orthobiologics-market/request-sample

North America held the majority of the global orthobiologics market in the recent past. The high demand in the market was sustained by increased prevalence of arthritis and obesity in the region, rising demand for the treatment of various diseases such as osteoarthritis and spinal injuries. However, over the next eight years, Asia-Pacific is projected to witness the highest rate of growth for orthobiologics market. This growth will be majorly driven by the Indian and Chinese market on account of a huge number of untapped patient population, economical cost, and medical tourism.

The major industry players operating in the global orthobiologics market include Stryker Corporation, Synthes, Inc., Biomet, Inc., DJO Global, Zimmer Holding, Inc., Medtronic, Inc., and Smith & Nephew, Bacterin International, Inc., DePuySynthes, Inc., Globus Medical, Inc., and Integra LifeSciences Corporation.

Increase in demand is driven by increased risk factors among people

Cardiovascular diseases pertain to the blood vessel and heart conditions that can affect the heart valve, cardiac muscle with the circulation system that monitors the blood flow and distribution and the cardiac electrical system which controls the heart rhythm and rate. These complex systems are taken care of by the cardiovascular therapy device market owing to the increasing number of global population being affected by the above mentioned diseases. The cardiovascular therapy market is expected to grow in the forecast period owing to introduction of improved technologies and devices that provide solutions for Cardio vascular diseases.

Growth in the global cardiovascular therapy market is attributed to factors owing to increasing worldwide prevalence of chronic CVDs and a higher percentage of aging population. Improvements in treatment capabilities in developing markets owing to technological advancements and innovation is expected to have a positive impact on the demand for cardiovascular thereupatic devices in the medical and healthcare sector. Technological advent with respect to therapeutic devices includes development of extended product life, smaller devices, and surgical improvements. Increase in demand is also driven by increased risk factors (diabetes, smoking, obesity, and hypertension) among people

In-Depth research report on Cardiovascular Therapy Market:

https://www.millioninsights.com/industry-reports/cardiovascular-therapy-market

Key application of in cardiovascular therapy is the hybrid operation rooms market that emphasizes on minimal invasive surgeries. Therefore, Global cardiovascular therapy market is expected to witness a growth owing to increasing demand for minimally invasive surgeries. However, high costs for treatment and safety concerns are major challenges before the market.  Cardiovascular therapy comprises of Anti-hypertensives, anticoagulants, anti-arrhythmic, Antithrombotics and Antidyslipidemics. Global cardiovascular market had a sale of $170bn in 2010 and is expected to have a positive growth in the forecast period. With a share of 40% of the total market, the US continued to be the market leader in this segment. Although there has been a decline in the sales of cardiovascular therapy market due to saturation of key drug categories and an increased generic presence, the US witnessed a steady growth in the market since 2009 and is expected to continue the same trend.

Antihypertensives remained the largest drug class in the past few years with global sales of over $37.6bn and an overall market share of over 22%. Angiotensin receptor blockers (ARBs) is expected to remain the most prescribed therapeutic class within antihypertensives driven by key brands such as Cozaar, Diovan, and Avapro. Novartis’s Diovan is the market leader with $3.6bn in sales and the second largest being Benicar with sales of $2.9bn.  The anticoagulants segment is expected to witness significant activity over the forecast period owing to introduction of new drugs such as BoehringerPradaxa/Rendix, Ingelheim's, Bayer-Schering/J&J's, BMS/Pfizer's apixaban, Xarelto and Eli Lilly/Daiichi's Effient which are subjected to intensive R&D activities. Since most of the factor Xa inhibitors are in oral form, they are expected to cater to a wider market.

Crestor is expected to witness a steady growth in the market owing to positive trial results that has the capability to strengthen its market position. The positive trial data is likely to result in higher number of recommendations for cholesterol treatment and capture more number of patients with cardiovascular disorders GlaxoSmithKline's (GSK) is expected to have the highest growth among leading players owing to the acquisition of Reliant Pharma. Addition of new drugs such as Lovaza in GSKs portfolio is a key factor that can drive the growth in this segment  In 2010, Antithrombotics recorded a sale of over $18.7bn and a market share of over 11%. Antithrombitics are forecasted to witness a strong growth in the next seven years owing to increase in the commercialization of recently approved products such as Xarelto, Pradaxa and launch of Pfizer/BMS’s apixabanBetter bleeding profile and superior effectiveness of Brilinta (ticagrelor) over Plavix make it major antithrombotic drug that could be a key player in acute coronary syndrome (ACS).

Browse reports of similar category available:

https://www.millioninsights.com/industry/healthcare

A large segment of atherosclerosis patients who do not respond to Plavix can be administered by Brilinta which has a potential therapeutic advantage in atherosclerosis Moreover, its use could be initially confined to acute coronary syndrome (ACS) with no patient monitoring anticipated for postmarketing surveillanceor respiratory or cardiac function requirements. The anti-arrhythmic market is expected to remain a small opportunity as this drug therapy has substantial limitations. New therapeutic standards and benchmarks are expected to be set by Multaq from Sanofi-Aventis owing to its first-line treatment of chronic atrial fibrillation.

Future technologies that are expected to have a positive impact on the market are third generation VADs in cardiac surgery that have the property to easily be implanted, Interventional cardiology that employs innovative therapies such as stem cell therapies and bioabsorbable stents, electrophysiology that focuses on developing implants that does not use lead and advanced endovascular therapy. Key regional segments include Europe, North America, Asia Pacific, Latin Americaand MEAIn 2014, Asia Pacific held the majority of share in global cardiovascular therapy market. Key factors contributing to its large share include prevalence of the target diseases such as hernia and congenital heart diseases. North America is expected to be the fastest growing regions over the forecast period. Health awareness among consumers and presence of improved healthcare infrastructure and pertaining to the availability of new products is expected to increase the use of cardiovascular over the forecast period.

To get free request sample:

https://www.millioninsights.com/industry-reports/cardiovascular-therapy-market/request-sample

Chemiluminiscence Imaging has a better playing field in developed economies

Chemiluminiscence Imaging or commonly known as CLIA is a doctrine predominantly witnessed in healthcare sector and blotting techniques and its relevance in detection of cancer has been well-documented. Chemiluminiscence transpires or better still molecules of light are emitted when luminol, synthetic compound (C8H7N302) reacts with an oxidizing agent viz hydrogen peroxide. Chemiluminiscence imaging marks its presence in forensic analysis by detecting traces of blood with iron content that emits a blue light under influence of an oxidizing agent or an oxidant.

Yet again, blue light emission states presence of copper cyanide and specific proteins as they come in contact under influence of an oxidant in an observed chemical reaction. Secondary equipment coming in handy is a HD camera for imaging. Chemiluminiscence also is used in biological assays to detect presence of biomolecules and traces of inorganic ions. Luminescence accepts various sequences as biochemical for bioluminescence, photons for photoluminescence and electromagnetic as electroluminescence based on excitation event.

Segmentation of chemiluminiscence imaging market by applications include chemiluminiscence immunoassays, hormones, insulin, thyroxin, estradiol, vitamin Vit 12, tumor markers, DNA hybridization detection, souther blotting, hybridization, western blotting, forensic science, food analysis, find organophosphorus most popular pesticide (Qunalphos).

Read full research report:

https://www.millioninsights.com/industry-reports/chemiluminiscence-imaging-market

Segmentation of chemiluminiscence market by region includes North America, Europe, Asia Pacific, MEA and Latin America. North America is foremost player in field of chemiluminescence imaging followed by Europe. The chemiluminiscence market is witnessing a high growth trajectory in North America and Asia pacific with established presence of big players in the field of chemiluminiscence imaging.

Chemiluminiscence is a highly fragmented market with too many players in contention, both local and international. Product launches such as Odyssey launched by LI-COR Biosciences and with uncluttered use in segments across industries such as biological and food analysis market drives growth in chemiluminiscence market. Drivers to the chemiluminiscence market include its preferential use in food, medical and forensic industry and in pre-clinical tests and R& D by research institutes and pharmaceutical laboratories.

Product development has wide scope in research and development laboratories using chemiluminiscence imaging enhancing growth in chemiluminiscence imaging market. As per industry news, chemiluminiscence immunoassays offer best solutions for quantification of low concentration of samples from an ambiguous mixture in comparison to RIA.

The non-radioactive nature of technique is better still in applications ranging from microbiology, Agriculture, therapeutic and clinical segments. CLIA has a better playing field in developed economies such as North America and Europe being a fully automated version. Key industry players in chemiluminiscence imaging market include LI-COR Biosciences, Analytik Jena US, Azure Biosystems, Berthold Technologies GmbH & Co., KG, Syngene, GE Healthcare, Thermo Fischer Scientific, Analytic Jena Life Science and PerkinElmer, Inc. 

Download free request sample:

https://www.millioninsights.com/industry-reports/chemiluminiscence-imaging-market/request-sample

Increasing presence of medical device companies that comply well with the pre-clinical studies in in-vivo experiments

Industry Insights

The global Preclinical Imaging Market size was worth USD 1.8 billion in 2015, which is anticipated to grow at a CAGR of more than 8.1% during the forecast period. Constant technological advancements and increasing expenditure on research and development are some of the leading factors for such huge market size with more and more pharmaceutical companies targeting this market. Similarly, rise in the number of contract research manufacturing and increasing presence of medical device companies that comply well with the pre-clinical studies in in-vivo experiments would further drive the market growth.

Use of various computerized database systems with advanced technology has increased over the years due to implementation of stringent laws and policies on animal testing which prevents exploitation of animals. Pre-clinical imaging has led to extraction of extremely detailed images of organs, cells, tissues and their anatomical features before and after the drug intake. Such methods of imaging along with micro-dosing, in-vitro tests have become an alternative for conventional methods.

Preclinical imaging systems include MRI, CT scan that is categorized under non-invasive techniques and possesses great potential to grow in the coming years. Some of the major factors that may challenge the acceleration of the market is increased cost, lack of skilled staff, underdeveloped infrastructure and non-availability such technically advanced devices in the third world countries.

Government bodies of developing countries such as Japan, Mexico, and Brazil, are making huge investments to spread awareness about the use of pre-clinical devices for research studies, and thereby focusing on quality and safety. Regions such as Latin America, Middle East and Asia Pacific are witnessing increase in foreign investments, which is leading to greater revenue generation, for the market growth.

Segment Insights

The optical imaging segment captured the largest market share in 2015 due to increased use of small animals in a number of animal research projects.

The fastest growth rate in the market was exhibited by multi-modal systems segment during the forecast period due to enhancement in integrated systems, which enable multiple screening in single device. It helps to achieve a detailed digital imaging of anatomical features for the organs of animals. A significant share of the market is being shared by the reagent segment, which showed higher frequency of purchases as compared to other segments.

Introduction of various features in imaging devices have resulted in increased number of applications. The development of various cancer therapies has benefitted from such up gradations in the technology, which makes it useful for numerous purposes. Other sectors, which have gained from the use pre-clinical imaging, includes obstetrics, gynaecology and cardiology.

Regional Insights

North America dominated the pre-clinical imaging industry capturing the largest revenue share in 2015, due to the fact that the region has maximum number of skilled workmen, developed infrastructure, higher acceptance and adoption of advanced technical devices and presence of large number of research projects which are being carried out.

In some regions including Canada, there have been various government initiatives and policies, which have helped in enhancement of research and development work in the form of funding and exemption from tax. All these factors can be attributed to conclude that North America will be a dominating region in this market, in terms of revenue.

Factors such as increased government funding, liberal government laws, growing adoption of contract research organisations, affordable research cost is contributing towards the highest CAGR of Asia Pacific region. .India and China are the key leaders in the Asia Pacific region, making it one of the most booming regions for the preclinical imaging market.

Competitive Insights

The global pre-clinical imaging market consists of international as well as local players. The capital required for the companies to enter in this market is comparatively lesser. The major players in this market are Siemens A.G., TriFoil Imaging, PerkinElmer, Inc., Mediso Ltd., General Electric(GE), Bruker Corporation, VisualSonics Inc. (Fujifilm), Mediso Ltd., MILabs B.V., and Agilent Technologies.

A huge pool of companies is focused towards advancing in the pre-clinical imaging market after thorough research and development in this sector. The most common strategy opted by companies are through mergers acquisitions and collaboration in order to gain maximum share in the market.

Read full research report:

https://www.millioninsights.com/industry-reports/preclinical-imaging-market

Download free request sample:

https://www.millioninsights.com/industry-reports/preclinical-imaging-market/request-sample

Gas exchange support and hemodynamic support is provided by the veno-arterial ECMO system

Industry Insights

The global Extracorporeal Membrane Oxygenation (ECMO) market size was valued at USD 246.5 million in 2016 and is expected to grow at CAGR of 4.3% over the forecast period. The major factors boosting growth are the rising incidences of Chronic Obstructive Pulmonary Disorder (COPD), and surging prevalence of cardiopulmonary diseases and respiratory failures.

According to data recorded by the American Lung Association (ALA), in 2013, COPD was recorded to be the third largest cause of death across the U.S. In addition, over 24.0 million individuals are estimated to remain undiagnosed in the U.S. and 11.0 million diagnosed for COPD.

Also, the increasing adoption of unhealthy lifestyles, such as rise in the total tobacco consumption level among both, females and males and further development of lifestyle disorders are augmenting the incidence rate of COPD. ECMO machines are gaining popularity in the hospital and healthcare systems due to the rising trend of its application during cases of respiratory disorders.

The ECMO machines are used in cases of cardiac failure to facilitate auxiliary oxygen support system. These machines are frequently used in patients suffering from respiratory conditions and also in neonates and pediatric patients. The estimated growth of these machines can be attributed to the critical nature of the target population consisting of neonates and pediatric patients.

Modality Insights

The segmentation of the key modalities is done on the basis of the different setups that are provided by the ECMO circuit such as arterio-venous, veno-arterial and veno-venous. They are used to provide hemodynamic support and to facilitate gaseous exchange in patients with cardiac or respiratory failure.

Both gas exchange support and hemodynamic support is provided by the veno-arterial ECMO system. It majorly works by passing the blood flow from the patients’ heart and lungs to the ECMO circuit. The veno-venous ECMO system on the other hand facilitates sole gas exchange support in which the blood is made to return to the heart prior to pulmonary circulation. According to the U.S. National Institute of Health (NIH), combination of veno-venous and veno-arterial is used in specific cases such as cardiogenic shock.

Applications Insights

As per applications, the market is segmented into Extracorporeal Cardiopulmonary Resuscitation (ECPR), respiratory and cardiac. The segments are further segmented on the basis of who is using the set up into adult application, neonate and pediatric. The segment dominating the market in 2015 with about 40.0% of the industry share is respiratory based ECMO.

The increasing demand for the ECMO systems is majorly attributed to rising number of patients with chronic respiratory conditions like COPD, emphysema and chronic bronchitis combined with a trend of growing awareness about health disorders. As per the U.S. National Center for Health Statistics, more than 8.7 million individuals suffered from chronic bronchitis and 3.4 million individuals suffered from emphysema in the year 2014.

Regional Insights

The major regions in this market are North America, Europe, Asia Pacific, Latin America and MEA. North America has grown considerably in this segment majorly attributed to the well developed primary, secondary and tertiary care hospitals combined with the reimbursement network, increasing awareness about the ECMO system facilitating their rapid adoption in the hospitals and favorable government funding.

Refinements in the technology presently in use was made by Terumo Cardiovascular Systems Corporation during the production of CAPIOX FX Oxygenator. This system is expected tohelp in increasing the blood rate and offer complete control over the entire process.

Competitive Market Share Insights

Some key players operating in the ECMO market include MAQUET Holding B. V. & Co. KG, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group, Medtronic, Plc., Terumo Cardiovascular Systems Corporation, and Nipro Medical Corporation. The major strategic initiatives adopted by the companies in this vertical are technological advancements in the existing portfolio and new product development.

For example, Medtronic Plc designed Minimax Plus Oxygen System for patients from wide ranging age groups such as from neonates to children, with features such as venous air director and low arterial port, which are integrated in the system to increase the safety levels and performance.

Read full research report:

https://www.millioninsights.com/industry-reports/extracorporeal-membrane-oxygenation-ecmo-market

Download free request sample:

https://www.millioninsights.com/industry-reports/extracorporeal-membrane-oxygenation-ecmo-market/request-sample

Devices of GERD serves as a substitute for management of heartburn

Industry Insights

The global Gastroesophageal Reflux Disease (GERD) therapeutics market size was valued at USD 5.66 billion in 2016 and by is estimated to be USD 4.34 billion by 2025, it is anticipated to observe a decrease in its revenue at a negative CAGR of -2.9%. Expiration of patented blockbuster drugs, which are indicated for the management of disorders of acid reflux is major restraining factors for this market.

With strong clinical pipelines and patent litigations, the market continues to experience significant changes. Proton pump inhibitors (PPI) and antagonists of histamine H2 receptor have the importance in current scenario of the market.

Upon loss of patent protection of formerly leading branded drugs, generic molecules with low-price can ingest the sales of the branded ones up to 90%. Rising number of companies being exposed to price scrutiny associated with shift in the focus of government on the promotion of consumer convenience will stimulate further reduction of drug prices. Although market turnover is affected by the expiration of major patents and the demand of drugs used to reduce acid, due to the increasing prevalence of heartburn, is anticipated to increase in the upcoming years.

The devices of GERD serves as a substitute for management of heartburn, because of low rate of success and failure in clinical trials. Hence, very limited acceptance of devices of GERD management contribute for the rising demand of drugs having acid neutralizing property, as the major therapy approach.

Nevertheless, the advent of devices which are minimally invasive to address anatomical defects are gaining popularity coupled with supportive evidence from clinical data for performing various procedures including trans oral fundoplication, which helps in preventing reflux of non-acid and acid contents. The adoption of these devices have been further reinforced in the U.S. in 2016 with the advent of a CPT code (43210) which helps in facilitating reimbursement process.

Drug Type Insights

In 2016, market was dominated by the antacids segment and is anticipated to keep its top position over the forecast period. Most preferred first-line therapy for infrequent and mild symptoms is antacids, as the therapy neutralize the secretion of gastric acid immediately. Convenient OTC (over-the-counter) accessibility various forms such as syrups, powders and tablets is accountable for the extreme adoption. Moreover, the AHFS (American Hospital Formulary services), amongst other countries, enlisted over 120 preparations too advocate.

In 2016, the second largest segment was found to be PPIs as it is the most common medication prescription type for the diseases such as heartburn. Generics inflow leading to the loss of exclusiveness of popular drugs, including Prilosec and Nexium, is estimated to negatively affect the sales of branded versions. A further decrease is appearing more with the expected expiration of other patented drugs, such as Dexilant.

Regional Insights

In 2016, the largest region was found to be North America in terms of share for GERD market. Every year, GERD symptoms are experienced by more than 80 million people in the U.S., of which, approximately 25 million patients suffer from acid reflux and heartburn daily and approximately 60 million patients monthly.

Moreover, outpatient clinic visits for GERD disorder in the U.S. has been increased in the past few years because of the more prone geriatric population to develop acid reflux and heartburn. On the contrary, the Asia Pacific is estimated to witness the fastest growth rate. The increasing geriatric population and dietary and lifestyle risk factors such as diet with high fat and obesity, is anticipated to drive the growth. In developing countries, the inclination towards self-medication is quickly increasing because of the affordability and availability of OTC antacids as in China and India.

Competitive Insights

Competitive market, which is generics-driven is creating a pressure on the prices of drug with decreased retail sales, which will stimulate stationary growth in future. Companies producing them range from high to medium on the basis of competitive rivalry. Eisai Co., Ltd.; AstraZeneca PLC; GlaxoSmithKline PLC; Johnson & Johnson and Takeda Pharmaceutical Co., Ltd.; are some of the top key players. In addition, Daewoong Pharmaceutical Co., Ltd.; SRS Pharmaceuticals Pvt. Ltd.; SFJ Pharmaceuticals Group and Ironwood Pharmaceuticals, Inc. are some emerging companies.

Among others, RaQualia Pharma, Inc. and Ironwood Pharmaceuticals, Inc. are focusing more on development of new generic molecules, which involves novel and existing drug mechanisms as a part of the strategy to enter into the competition. Many generic players are also trying to focus on these spaces in an attempt to capture a larger share by the new version to replace the patent expired drugs.  

Read full research report:

https://www.millioninsights.com/industry-reports/gastroesophageal-reflux-disease-gerd-therapeutics-market

Download free request sample:

https://www.millioninsights.com/industry-reports/gastroesophageal-reflux-disease-gerd-therapeutics-market/request-sample

Increasing incidence of diseases is responsible for the rise in demand for therapeutics

Industry Insights

The global cell isolation/ separation market size was estimated at USD 3.6 billion in 2016. There has been a recent increase in the use of the cell isolation in the stem cells research and cancer studies by the biotechnology companies and pharmaceuticals. This has triggered immense demand for related products. The cell separation is used for advanced analytical procedures in cancer and stem cells research. This has resulted in high demand for proteins and in turn is expected to support the cell isolation market during the forecast period.

Personalized medicine is customized medical treatment for each individual which facilitates greater outcomes. The cell isolation market procedures can be used for personalized medicine for the early detection of the diseases and to provide proper treatment. The separation of different cell types is a vital step for research, diagnostics, biomedical, and biotechnological applications. Thus, the rising demand for personalized medicine is a major factor augmenting the cell separation products.

Product Insights

The product segment is fragmented into consumables and instruments. The consumables segment is estimated to account for the largest market share. The increase in investment in research and development activities by the biotech companies has led to a boost in the cell separation products. This has led to a surge in demand of the cell separation consumables adding to the segment growth.

The instruments segment is projected grow at a significant rate due to product development and advancement during the forecast period. This advancement is helpful in the efficient cell separation and diagnostics purposes. The increasing incidence of diseases is responsible for the rise in demand for therapeutics which in turn is adds to the growth of the separation products.

In-Depth research report on Cell Isolation/Separation Market:

https://www.millioninsights.com/industry-reports/cell-isolation-separation-market

Type Insights

The wide use of the stem cells in various applications like biopharmaceuticals and other research is a major factor for the growth of the cell separation market. Moreover, the rise in R&D procedure for new product development and clinical trials also add to the cell isolation market share. The animal type is expected to show a fair amount of growth in the forecast period.

The growing government focus on the development of the newer drug discovery along with investments from pharmaceuticals has attributed to the growth of the cell separation market. The drug discovery and research require animal cells for the examination of the preliminary toxicity and efficacy of the new molecule. Thus, the increasing government rigidness regarding animal cells and tissue availability are expected to hinder the market growth.

Technique Insights

There are different techniques including centrifugation, surface maker, and filtration that are used for cell isolation. The centrifugation segment is expected to hold largest market share in 2016. The rise in the application of cell isolation in the research laboratories, biotech institutes, biopharmaceutical companies and cell banks is accelerating the sector growth during the forecast period.

The filtration and surface marker segment is expected to show significant growth rate during the study period. Product development and rising investment in pharmaceutical manufacturing has led to increased share of the segment. The advanced filtration systems are used for research and production by the manufacturers for assuring the better quality of end product.

Browse reports of similar category available:

https://www.millioninsights.com/industry/biotechnology

Application Insights

The biomolecule segment is reported to have the highest revenue share in 2016. The increasing focus on the production of the biopharmaceuticals such as monoclonal antibodies, biosimilars, and proteins add to the segment growth. Moreover, the increasing research investments and government funding has propelled the sector growth.

The cancer and stem cells research segment are expected to exhibit rapid growth in the forecast period. The growing investments made by the pharmaceutical companies in stem cells research is a major factor responsible for the growth of the segment. Investments are expected to yield newer products in the research process, ultimately increasing the demand for the novel and efficient techniques used in stem cells research adding to the market growth.

End User Insights

The end users segment is further categorized into research laboratories, institutes, and biotechnology & biopharmaceutical companies. The research laboratories and institutes segment accounted for the largest market share in 2016. This is due to the increased prevalence of the stem cells and cancer research.

The biopharmaceutical & biotechnology companies segment accounted for remarkable revenue share in the market. This is due to an increase in the R&D investment by biologics manufacturers for research activities related to protein therapeutics, monoclonal antibody, and cancer & stem cells research, which is expected to boost the demand for cell isolation products.

Regional Insights

North America accounted for the largest market share in the 2016. Presence of major biotechnology companies and pharmaceutical companies in the region as well as highly developed infrastructure has contributed to the growth of the regional sector. In addition, product advancements and drug discoveries in the region is further anticipated to boost growth.

Several biotechnology and pharmaceutical companies are penetrating the Asia Pacific region owing to high target population base, increasing disposable incomes, cheap labor, and rapidly growing economy. With highly populated countries, offer a large gene pool for more research thus. further helping the cell isolation market in the region. Moreover, there are less stringent regulations along with the availability of the skilled but cheap worker which add to the market growth.

Competitive Insights

Some of the key players in the market are BD Biosciences; Thermo Fisher Scientific, Inc.; Merck KGaA; Beckman Coulter, Inc.; GE Healthcare; STEMCELL Technologies Inc.; Terumo BCT; and Bio-Rad Laboratories, Inc. The increasing merger, acquisition, and collaboration between the companies have profited the cell isolation market growth. For instance, In August 2016, STEMCELL Technologies Inc. and GE Healthcare announced a licensing agreement. According to which STEMCELL Technologies’ T-Cell reagents will be commercialize by GE Healthcare. This reagent can be used for the separation, culture, and activation of T-cells in clinical applications. Moreover, the newer product launch and regional expansion have also attributed to the market growth.

To get free request sample:

https://www.millioninsights.com/industry-reports/cell-isolation-separation-market/request-sample

Carcinoembryonic antigens are the most cost effective technique for the preclinical detection of illness

Industry Insights

The global Carcinoembryonic Antigen (CEA) market is expected to reach USD 2.56 Billion by 2022, which is anticipated to grow at a CAGR of more than 6.6% during the forecast period. The market is expected to witness significant growth in the coming few years owing to various key attributes such as growing incidence of cancer and technological advancement regarding the development of novel biomarkers. According to WHO estimates in 2015, globally cancer is the second leading cause of death with over 8.8 million deaths. On the basis of the Age-Standardized rate of incidence, there are approximately 205 new cases of cancer for every 100,000 men and nearly 165 new cases of cancer for every 100,000 females in the world. Carcinoembryonic antigens are the most cost effective technique for the preclinical detection of illness.

Technological advancements pertaining to proteomics, which include protein bioinformatics, mass spectroscopy, protein labelling, imaging, and array based approaches, is one of the crucial factors expected to fuel up the market growth. Development of new biomarkers and various immunological techniques such as radioimmunoassay that can be used with carcinoembryonic antigen (CEA) for detection of various types of cancers, and thus also propel the market growth. For instance, the development of tumor markers, which is used in combination with CEA for detection of colorectal cancer. Favorable government initiatives to introduce new diagnostic tools/technologies is anticipated to boost the market growth. Moreover, rising demand for minimally invasive diagnostic procedures to avoid the various post procedure adverse effects impel the growth of this market.

Application Insights

This segment include key application, namely colorectal, ovarian, pancreatic, breast, thyroid and other cancer applications. In 2016, colorectal cancer dominated the market in terms of revenue share. Rising incidence of colorectal cancer and increase sensitivity to detect the antigen are the factors driving the growth of this segment. According to the American Cancer Society, in the U.S colorectal cancer is the third leading cause of death in women and second in men with nearly 95,520 new cases of colon cancer. Furthermore, increased consumption of alcohol, less physical activity, unhealthy diet, and rapidly changing lifestyle also contribute in the growth of colorectal cancer in the recent years.

Breast cancer is another segment experiencing significant growth owing to the factors such as rising female population above 50 years, advancements in biomarkers and increase in number of patients undertaking hormone replacement therapy (HRT), and breast augmentation & reconstruction surgery. Increasing government initiative coupled with rising consumer awareness for different treatment procedures is also driving the growth of the market. Moreover, other breast related diseases such as infections, lesions, and fibrocysts are also expected to contribute towards the growth in early diagnosis.

Regional Insight

Regional segments of CEA market include North America, Europe, Asia Pacific, Latin America and MEA. In 2016, North America dominate the regional market pertaining to various key attributes such as increasing patient awareness, rising incidences of cancer, favorable reimbursement policies, and presence of advanced healthcare infrastructure. According to American Cancer Society in 2017, approximately 1,688,780 new cases of cancer were estimated in the U.S.

Asia Pacific region is expected to grow at lucrative rates during the forecast period owing to the factors such as increasing prevalence of cancer in emerging economies such as Brazil, Russia, India, and China, favorable government initiatives, and significant presence of local players will drive the growth of the market in this region. Asia Pacific has the highest mortality rate accompanied by North America. It has influenced the market in terms of cancer incidence rate affecting large population in 2012 at a changeable rate. Mexico and Brazil in Latin America will witness significant growth in the market owning to the factors such as increase alcohol consumption, excessive smoking, and changing lifestyles.

Competitive Insights

The global carcinoembryonic antigen market is consolidated in nature with extensive mergers and acquisitions. In 2017, Aviva Systems Corporation (ASB), a protein solutions and application provider is offering products for both research and diagnostic market acquired GenWay Biotech, Inc. Some of the key players in this market include F. Hoffmann-La Roche Ltd; GenWay Biotech, Inc.; Abbott; Correlogic Systems, Inc.; Quest Diagnostics, Inc.; Lee BioSolutions; RayBiotech, Inc; Biocare Medical, LLC; and Abcam plc. Industry competition level is expected to remain at moderately high level in the recent years Manufacturers are continuously introducing technologically advanced products that will raise the competition in the market.

Read full research report:

https://www.millioninsights.com/industry-reports/carcinoembryonic-antigen-cea-market

Download free request sample:

https://www.millioninsights.com/industry-reports/carcinoembryonic-antigen-cea-market/request-sample

Global bone densitometers is predicted to grow with a CAGR of 3.9% during the forecast period

Industry Insights

The market size of global bone densitometers was worth USD 893.7 million in the year 2016 and is predicted to grow with a CAGR of 3.9% during the forecast period. The significant increase in prevalence of osteoporosis on global level is the major driving force. This has led to an upsurge in demand for efficient assessment with the use of bone densitometers. In addition, the increase in geriatric population base, which is more susceptible to metabolic bone diseases, is expected to provide lucrative growth opportunities.

The rise in osteoporosis incidence in menopausal women is anticipated to be a key growth contributor. According to International osteoporosis foundation, over 200 million females are suffering from this disease globally with 1/10th belonging to 60 years, 2/5th in 80 years’ group, 1/5th in 70 years and 2/3rd in 90 years’ age group. Moreover, every 1 out of 3 women above the age of 50 years were seen to suffer from fragility fractures once in their lifetime.

According to a report published by National Institutes of Health Osteoporosis and Related Bone Diseases, various lifestyle-related factors including smoking, alcohol abuse and sedentary lifestyle are major contributors for development of osteoporosis in males. The above mentioned factors provide a clinical urgency to reduce this disease burden and hence fuel the rate of adoption of these assessment devices to suffice early diagnosis.

Additionally, advent of technologically advanced products such as ultrasound & computer assisted densitometers and integrated digital detectors cater to the needs of technicians and physicians by reducing measurement time and facilitating easy operations. The use of ultrasound based densitometers has increased to wide range of fields including endocrinology, gynecology and various others.

Browse full research report:

https://www.millioninsights.com/industry-reports/bone-densitometers-market

Furthermore, the increase in demand for these devices can be attributed to the collaborative initiatives undertaken by key companies for research and development of new products to enhance the diagnostic tools for advanced skeletal assessment. Also, funds for research by various healthcare organizations for development of technologically advanced products are also projected to drive the market. For instance, Lunar Expert developed by GE Healthcare provides spatial resolution leading to enhanced risk assessment and identification via advanced visualization.

Technology Insights

The largest share in the technology segment was held by axial bone densitometers with over 60.0% in 2016 as a consequence of consistent adoption rate of these devices. The fulfillment of various requirements and needs of clinicians by usage of these devices can be attributed to the increasing penetration rate of the technology. These majorly include the central dual energy x-ray absorptiometry, technology based tools which are crucial for accurate diagnostic results.

Moreover, the usage of these bone assessment devices are predicted to be a result of enhanced precision, sensitivity, optimum linearity leading to reduced variation in diagnostic performance. The above mentioned factors along with their cost effective nature are responsible for the high adoption of these by clinicians.

End-use Insights

The major share was held by hospitals in 2016 owing to the large volume of patients and frequent readmission. Moreover, sophisticated infrastructure facilitating high efficiency of diagnostic procedures with bone assessment devices is expected to drive the hospital segment.

The rise in initiatives by healthcare organizations to promote technologically advanced and sophisticated instruments for rapid result generation also serves as a key growth driving factor. In addition, hospitals in present scenario are using totally automated systems having the ability for assessment of conditions at an early stage. The aforementioned factors are predicted to positively impact the segment growth during the forecast period.

Regional Insights

The market was dominated by North American region in 2016 owing to the rising osteoporosis burden of the region. Various strategic initiatives by prominent market players for improvement of R&D capabilities and maintaining high medical standards are anticipated to drive the regional demand.

The growth across Asia Pacific region is expected to be exponential throughout the forecast period with a CAGR of xx%. The high growth can be attributed to the rise in demand to reduce the existing prevalence, increased disposable income and improvements is infrastructure of healthcare facilities. The developing economies including China and India presents a potential growth opportunity in the forecast period owing to the high awareness level related to osteoporosis care.

Competitive Insights

The intensive competition in the industry is expected to rise throughout the forecast period as a consequence of increasing number of strategic initiatives such as new product development, R&D investments, acquisitions and mergers by prominent market players to maintain their competitive edge over the other companies.

For example, Hologic, Inc. in August 2014 received regulatory approval for horizon DXA platform in Canada having workflow efficiencies and enhanced technical capabilities. The integrated ceramic detector array and high resolution achieved by the devices helps in enhanced stability, precision, image quality and skeletal mapping.

To get free request sample:

https://www.millioninsights.com/industry-reports/bone-densitometers-market/request-sample